Brief: AngioDynamics Presents APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System In Treatment Of Pulmonary Embolism

AngioDynamics

06/05/2024 22:51

May 6 (Reuters) - AngioDynamics Inc  ANGO.O :
    * ANGIODYNAMICS’ APEX-AV TRIAL RESULTS ASSESSING ALPHAVAC
F18⁸⁵
SYSTEM IN TREATMENT OF PULMONARY EMBOLISM PRESENTED AT SCAI 2024
SCIENTIFIC SESSIONS
    * ANGIODYNAMICS INC: NEW DATA FINDS ALPHAVAC F18(85) SYSTEM
SAFE
IN PATIENTS WITH ACUTE INTERMEDIATE-RISK PULMONARY EMBOLISM
    * ANGIODYNAMICS INC:  NEW DATA FINDS ALPHAVAC F18(85) SYSTEM
PROVIDES SIGNIFICANT IMPROVEMENT IN RIGHT VENTRICULAR FUNCTION
AND REDUCTION IN CLOT BURDEN

Source text for Eikon:  ID:nBw7k7q66a 
Further company coverage:  ANGO.O 

 ((Reuters.Briefs@thomsonreuters.com;))